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To localize P-hydroxyaspartic acid in factor IX and factor X the two proteins were cleaved with cyanogen 
bromide and trypsin, respectively. Peptides containing&hydroxyaspartic acid were isolated and subjected 
to Edman degradation. The phenylthiohydantoin derivative of P-hydroxyaspartic acid was identified by 
HPLC in position 3 in the factor IX fragment and in position 1 in the factor X fragment. This corresponds 
to position 64 in factor IX and position 63 in the light chain of factor X. The assignments were con~rmed 
by subtractive Edman degradation and with the dansyl method. 
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1. INTRODUCTION 
The vitamin K-dependent plasma proteins con- 
tain lo-12 y-carboxyglutamic acid residues, which 
are formed by posstranslational carboxylation of 
glutamic acid residues in a vitamin K-dependent 
reaction [l-3]. The y-carboxyglutamic acid resi- 
dues are prerequisites for Ca2’ binding and bio- 
logical activity. Recently, another posttranslation- 
ally modified amino acid, erythro-fl-hydroxyaspar- 
tic acid, was found in bovine protein C [4] and in 
human factor X [5]. ~-Hydroxyaspartic acid has 
thus far been identified in all the vitamin K-depen- 
dent plasma proteins except prothrombin and in 
none of a number of other common proteins 
studied [6,7]. As judged from amino acid analysis 
of acid hydrolysates factor X, protein C and pro- 
tein 2 all contain about 1 mol fl-hydroxyaspartic 
acid per mol protein whereas factor IX seems to 
contain less than 1 mol per mol protein [6]. Protein 
S on the other hand contains 2-3 mol P-hydroxy- 
aspartic acid per mol protein 161. Although P- 
hydroxyaspartic acid had not been found in pro- 
teins prior to its identification in the vitamin K- 
dependent ones it had been demonstrated in urine 
[8] and in microorganisms [9]. Specific analysis has 
* To whom correspondence should be addressed 
demonstrated its absence in a number oi common 
non-vitamin K-dependent proteins [6]. The func- 
tion of ,&-hydroxyaspartic acid in the vitamin K- 
dependent proteins is not known. 
In protein C the ~-hydroxyaspartic acid residue 
is in position 71 of the light chain [lo]. In this 
region protein C, factor IX and factor X show a 
pronounced sequence homology [lo]. Recently, 
authors in [l l] published the sequence of a cDNA 
for bovine factor IX mRNA. In the position cor- 
responding to no. 71 in bovine C the cDNA coded 
for aspartic acid instead of threonine as has been 
reported in the protein sequence [12]. The rest of 
the sequence of the cDNA was in complete agree- 
ment with the published protein sequence. This 
suggested that the amino acid in bovine factor IX 
corresponding to position 71 in the light chain of 
bovine protein C is ,&hydroxyaspartic acid and 
furthermore that it is formed by posttranslational 
hydroxylation of an aspartic acid residue. We 
show here that the ,&hydroxyaspartic acid residue 
is in position 64 in bovine factor IX and in position 
63 in the light chain of bovine factor X. 
2. MATERIALS AND METHODS 
DL-threo-P-Hydroxyaspartic acid was obtained 
from Fluka. DL-erythro-fi-Hydroxyaspartic acid 
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was obtained by synthesis of racemic ,8-hydroxy- 
aspartic acid and separation of the DL-three and 
DL-erythro forms by ion exchange chromato- 
graphy [13]. TPCK-trypsin was obtained from 
Worthington and purified by HPLC [14]. Bovine 
factor IX and factor Xi were purified by standard 
procedures [15,16]. They were reduced and car- 
boxymethylated with iodo[2-14C]acetic acid as in 
[16]. The light and heavy chains of factor Xi were 
separated by gel filtration as described for protein 
C (161. 
HPLC was performed on a Waters liquid chro- 
matograph equipped with a model 600 solvent 
programmer. A 22-cm Aquapore RP 300 column 
(Brownlee Laboratories) was eluted with a linear 
gradient of acetonitrile in 0.1% (v/v) trifluoro- 
acetic acid (for details see fig.2 legend). This 
system was used for peptide isolation and for an 
improved analysis of the phenylthiohydantoin 
(PTH) derivatives of ,&hydroxyaspartic acid and 
aspartic acid. Amino acid analysis was performed 
after acid hydrolysis in 6 M HCl at 110°C for 24 h 
in vacua. A Beckman 119 CL single-column auto- 
matic analyzer with a conventional ninhydrin 
detection system was used. For quantitation of fl- 
hydroxyaspartic acid a Jeol 5AH amino acid 
analyzer was used after modification for increased 
resolution of acidic amino acids and fluorimetric 
detection with the o-phthalaldehyde reagent [4,6]. 
Automated amino acid sequence analysis was per- 
formed as in [lo] and the PTH-derivatives were 
identified by HPLC [ 171. Manual Edman degrada- 
tions were performed as in [18] with identification 
of the PTH-derivatives by back hydrolysis and 
with acid hydrolysis of the remaining peptide for 
quantitation of ,&hydroxyaspartic acid. Dansyl 
derivatives of amino acids and peptides were 
prepared with standard methods and identified by 
two-dimensional chromatography as in [ 191. 
The reduced and S-carboxymethylated light 
chain of bovine factor XI was digested with trypsin 
for 4 h at 37°C in 0.1 M NH4HCOs at an enzyme: 
substrate ratio of 1: 50 (w/w). After lyophilization 
the digest was chromatographed on a column 
(1.6 x 194 cm) of Sephadex G-50 equilibrated with 
10% formic acid and eluted at a rate of 9 ml/h. As 
judged from amino acid hydrolysates of the pooled 
fractions the ,&hydroxyaspartic acid-containing 
peptide was eluted earlier than and well separated 
from the other peptides (not shown). The peptide 
was lyophilized, extracted with 5% ethanol in 
0.1% trifluoroacetic acid and dried by rotary 
evaporation. It was then subjected to a second 
digestion with trypsin in 0.1% NHdHCOj, this 
time at an enzyme: substrate ratio of 1: 5 (w/w) for 
6 h at 37°C. The resulting peptides were separated 
by HPLC. 
Reduced and S-carboxymethylated factor IX, 
which has 3 methionine residues, was cleaved with 
CNBr (500-fold molar excess relative to methio- 
nine) in 70% formic acid [20]. After lyophilization 
the fragments were separated by chromatography 
on a column (1.6 x 94 cm) of Sephacryl S-200 in 
50 mM Tris-HCI (pH 7.5) containing 6 M guani- 
dine hydrochloride and eluted at 15 ml/h. The 
largest fragment, residues 62-349, suspected to 
have &hydroxyaspartic acid in position 3 was 
eluted in the first major peak. It was dialyzed 
against 0.1 M NH4HC03 and lyophilized. 
3. RESULTS AND DISCUSSION 
3.1. Identification of erythro-&hydroxyaspartic 
acid in bovine factor X 
The ,&hydroxyaspartic acid-containing peptide 
in factor Xi was isolated by sequential tryptic 
digestion. The first tryptic peptide (TO) isolated by 
gel filtration had an amino acid composition in- 
dicating that it contained residues 44-79 (fig.1). 
After a second tryptic digestion of this peptide at 
Fig. 1. Comparison of sequences urrounding the P-hydroxyaspartic acid residues in bovine protein C, bovine factor IX 
and bovine factor X. The blocks enclose residues identical with the residue in protein C. ,8 and y refer to P-hydroxy- 
aspartic acid and y-carboxyglutamic acid, respectively. The sequence of protein C light chain was taken from [lo] of 
factor IX from [12] of factor X light chain from [21]. 
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high enzyme: substrate ratio 3 peptides (Tl-T3) 
could be isolated by HPLC (fig.2). Amino acid 
analysis of Tl and T2 showed that they occupied 
positions 46-62 and 44-62 in the light chain, 
respectively. T3 contained fl-hydroxyaspartic acid 
and corresponded to residues 63-79 as judged 
from amino acid analysis and 14 steps of auto- 
mated Edman degradation. The amino acid com- 
position of the peptide T3 was CM-Cys 2.0, Asp 
1.2, Thr 1.8, Glu 2.2, Gly 4.0, Ala 1.0, Ile 1.0, Tyr 
0.9, Phe 1.0, Lys 1.4. The fl-hydroxyaspartic acid 
content of the light chain-was 0.73 mol/mol, the 
peptide TO (residues 44-79) contained 1.23, and 
the peptide T3 (residues 63-79) contained 0.90 
mol/mol peptide. The peptide T3 was isolated in 
an overall yield of 3 1% based on the recovery of 
,&hydroxyaspartic acid. In this context it is note- 
worthy that in the sequence determination of the 
light chain of bovine factor X authors in [21] ob- 
tained peptide T3 in high recovery from tryptic 
digests of the light chain at an enzyme:substrate 
ratio of 1: 50 (w/w) whereas we obtained virtually 
no cleavage at lysine 62 unless very high enzyme: 
substrate ratios were employed. A possible ex- 
planation for this difference is that they used 
vinylpyridine for cysteine modification and thus 
introduced a positive charge on the cysteine residue 
in position 61. We used iodoacetic acid which 
caused a negatively charged carboxymethylcysteine 
residue in position 61 and presumably contributed 
to the relative resistance of the adjacent lysyl-/3- 
hydroxyaspartyl bond to tryptic digestion. 
The amino composition of peptide T3 (residues 
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Fig.2. Chromatography of a tryptic digest of a peptide 
containing residues 44-79 from the light chain of factor 
X. About 540nmol was digested and applied to an 
Aquapore RP 300 column in 0.1% (v/v) trifluoroacetic 
acid and 5% (v/v) acetonitrile. A linear gradient to 70% 
acetonitrile was run in 60min. The absorbance was 
monitored at 214nm and the individual peaks were 
pooled. 
1 st dimension 
Fig.3. Polyamide thin layer chromatography of the 
dansyl derivative of erythro#-hydroxyaspartic acid 
(spot no. 8). The chromatogram was developed with 
formic acid/water (1: 15, v/v) in the first dimension and 
with formic acid/methanol/ethyl acetate (1: 1: 14, by 
vol.) in the second dimension. The compounds are (1) 
dansylamine, (2) glycine, (3) threonine, (4) serine, (5) 
glutamic acid, (6) aspartic acid, (7) carboxymethylcys- 
teine, (8) erythro-fi-hydroxyaspartic acid, (9) dansyl- 
hydroxide. 
63-79) was in complete agreement with the 
published sequence [21] except that one aspartic 
acid was missing. NHz-terminal acid analysis with 
the dansyl method gave an amino acid that mi- 
grated exactly as ,&hydroxyaspartic acid on two- 
dimensional polyamide thin-layer chromatography 
(fig.3). Manual Edman degradation of peptide T3 
in the first cycle gave a PTH-derivative which on 
HPLC eluted in the same position as the co-eluting 
PTH-aspartic acid and PTH-&hydroxyaspartic 
acid. There was no PTH-asparagine [21]. In a 
second HPLC analysis, which used an acid eluting 
system allowing separation of PTH-aspartic acid 
and PTH-,&-hydroxyaspartic acid, two doublet 
peaks were obtained (fig.4). The two first eluting 
peaks had mobilities identical with the two peaks 
obtained with synthetic PTH-,&-hydroxyaspartic 
acid and presumably corresponded to the erythro 
and threo forms of ,&hydroxyaspartic acid. The 
last peak in the second doublet (fig.4) had the same 
retention time as PTH-aspartic acid whereas the 
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Fig.4. KPLC with an acid eluting system of PTH- 
derivates obtained from the first step of manual Edman 
degradation of peptide T3 from the tight chain of factor 
X. Top, standard mixture with components denoted by 
the standard one letter code. ,& denotes the doublet 
obtained with ,@-hydroxyaspartic acid. NL is norleucine. 
Bottom, first step of manual Edman degradation. For 
experimental details, see text and legend to fig.2. 
first peak in this doublet did not correspond to any 
of the 20 common PTH amino acids. Acid hydro- 
lysis of the material obtained in the first cycle of 
Edman degradation of peptide T3 gave a small 
amount of aspartic acid on amino acid analysis but 
no ~-hydroxyaspartic acid. An identical treatment 
of synthetic PTH~-hydroxyaspartic acid led to 
destruction of the amino acid and recovery of 
some aspartic acid. It should be pointed out that 
PTH-serine and PTH-threonine are also destroyed 
by acid hydrolysis [18]. HPLC analysis of the 
material obtained by automated Edman degrada- 
tion of peptide T3 gave the same doublet cor- 
responding to PTH-,&hydroxyaspartic acid as with 
manual degradation but with a lower recovery 
(IS%), presumably due to less efficient extraction 
from the sequencer cup. ~-Hydroxyaspartic acid 
was also determined by acid hydrolysis in the re- 
maining peptide during the manual Edman de- 
gradation. As seen in table 1, @-hydroxyaspartic 
acid was almost completely removed from T3 with 
Table 1 
@-Hydroxyaspartic a id recovery during subtractive 
Edman degradation 
Stage Factor X 
T3 
(mol/mol peptide) 
Peptide 0.90 
1 0.06 
2 <0.05 
3 ND* 
4 ND 
* not determined 
Factor IX 
CBl 
(mol/mol peptide) 
0.94 
0.91 
1.07 
0.32 
0.31 
the first step of Edman degradation confirming the 
NHz-terminal position of P-hydroxyaspartic acid 
in the peptide and thus in position 63 in the light 
chain of factor X. With subtractive Edman analy- 
sis only a little racemization of P-hydroxyaspartic 
acid takes place during acid hydrolysis of the pep- 
tide 141. Therefore, as the two diasteromeric forms 
of ~-hydroxyaspartic acid are completely separated 
on the amino acid analyzer [4], it was possible to 
determine that the diastereomeric form present in 
the peptide is the erythro form. In contrast, the 
PTH-derivative of P-hydroxyaspartic acid seems to 
be almost completely racemized and therefore is 
not helpful in this respect. Neither can polyamide 
layer chromatography of the dansyl derivative of 
,&hydroxyaspartic acid be used since the two dias- 
teromeric forms do not separate completely in the 
thin-layer chromatographic system used. 
3.2. Identification of er~hro-~-~ydroxya~~artic 
acid in bovine factor IX 
The CNBr fragment (CBl) of factor IX contain- 
ing &hydroxyaspartic acid was isolated by gel 
filtration. Automated amino acid sequence deter- 
mination gave CM-Cys-Lys-X-Asp-Ile-Asn-Ser- 
Tyr, indicating that the fragment was residues 
62-349 in factor IX [12]. The sequence analysis is 
also indicated that the fragment was contaminated 
with 29% of a fragment with a sequence identical 
to the NHz-terminal sequence of intact factor IX, 
presumably caused by incomplete cleavage at 
methionine 61. In the third cycle the HPLC gave a 
PTH-derivative which eluted as a doublet in exact- 
ly the same position as the doublet obtained with 
synthetic PTH-fl-hydroxyaspartic acid. The re- 
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covery was about 8%. PTH-threonine was not 
found [12]. Subtractive Edman degradation of 
CBl (table 1) with P-hydroxyaspartic acid deter- 
mination in the acid hydrolysate of the remaining 
peptide clearly indicated an erythro-fl-hydroxy- 
aspartic acid residue in position 3 of CBl cor- 
responding to position 64 of bovine factor IX. 
However, about 0.3 mol/mol peptide of the amino 
acid was found even beyond position 3. This was 
caused by the contamination of CBl with a larger 
CNBr fragment due to incomplete cleavage at 
methionine 6 1. 
3.3. &Hydroxyaspartic acid in vitamin K-depen- 
dent plasma proteins 
This work has unambigously shown that p- 
hydroxyaspartic acid occupies position 64 in bo- 
vine factor IX and position 63 in the light chain of 
bovine factor X. These findings are in agreement 
with those in [5,7]. Until now ,&hydroxyaspartic 
acid has been demonstrated in the following posi- 
tions in proteins: position 71 in the light chain of 
bovine protein C, position 64 in bovine factor IX, 
position 63 in the light chain of bovine factor X, 
and in position 63 in the light chain of human fac- 
tor X. In all these proteins the ,&hydroxyaspartic 
acid residue occupies the corresponding position 
according to the sequence homology of the sur- 
rounding parts of the polypeptide chains. This pro- 
nounced conservation points to an important role 
of this unusual amino acid in vitamin K-dependent 
proteins. 
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